Maria Carolina Marchetto

Maria Carolina Marchetto

Auto-generated profile, based on publicly available information

Maria Carolina Marchetto

Department of Anthropology University of California San Diego La Jolla California USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2019 in eLife
Verified
Journal Article
Open access
MMMaria C Marchetto
Maria C Marchetto
BHBranka Hrvoj-Mihic
Branka Hrvoj-Mihic
BKBilal E Kerman
Bilal E Kerman
DYDiana X Yu
Diana X Yu
KVKrishna C Vadodaria
Krishna C Vadodaria
FGFred H Gage
Fred H Gage
Comparative analyses of neuronal phenotypes in closely related species can shed light on neuronal changes occurring during evolution. The study of post-mortem brains of nonhuman primates (NHPs) has been limited and often does not recapitulate important species-specific developmental hallmarks. We utilize induced pluripotent stem cell (iPSC) technology to investigate the development of cortical pyramidal neurons following migration and maturation of cells grafted in the developing mouse cortex. Our results show differential migration patterns in human neural progenitor cells compared to those of chimpanzees and bonobos both in vitro and in vivo, suggesting heterochronic changes in human neurons. The strategy proposed here lays the groundwork for further comparative analyses between humans and NHPs and opens new avenues for understanding the differences in the neural underpinnings of cognition and neurological disease susceptibility between species.

14 February 2017 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
YKYeni Kim
Yeni Kim
RSRenata Santos
Renata Santos
FGFred H. Gage
Fred H. Gage
MMMaria C. Marchetto
Maria C. Marchetto
Bipolar disorder (BD) is a chronic and progressive psychiatric illness characterized by mood oscillations, with episodes of mania and depression. The impact of BD on patients can be devastating, with up to 15% of patients committing suicide. This disorder is associated with psychiatric and medical comorbidities and patients with a high risk of drug abuse, metabolic and endocrine disorders and vascular disease. Current knowledge of the pathophysiology and molecular mechanisms causing BD is still modest. With no clear biological markers available, early diagnosis is a great challenge to clinicians without previous knowledge of the longitudinal progress of illness. Moreover, despite recommendations from evidence-based guidelines, polypharmacy is still common in clinical treatment of BD, reflecting the gap between research and clinical practice. A major challenge in BD is the development of effective drugs with low toxicity for the patients. In this review we focus on the progress made and future challenges we face in determining the pathophysiology and molecular pathways involved in BD, such as circadian and metabolic perturbations, mitochondrial and endoplasmic reticulum dysfunction, autophagy and glutamatergic neurotransmission; which may lead to the development of new drugs.

4 January 2021 in Molecular Psychiatry
Verified
Journal Article
Closed access
PDF file
RSRenata Santos
Renata Santos
SLSara B. Linker
Sara B. Linker
SSShani Stern
Shani Stern
AMAna P. D. Mendes
Ana P. D. Mendes
MSMaxim N. Shokhirev
Maxim N. Shokhirev
FGFred H. Gage
Fred H. Gage

18 July 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
AGAlessandra Giorgetti
Alessandra Giorgetti
MMMaria C. N. Marchetto
Maria C. N. Marchetto
MLMo Li
Mo Li
DYDiana Yu
Diana Yu
RFRaffaella Fazzina
Raffaella Fazzina
Juan Carlos Izpisua BelmonteJuan Carlos Izpisua Belmonte
Juan Carlos Izpisua Belmonte
The finding that certain somatic cells can be directly converted into cells of other lineages by the delivery of specific sets of transcription factors paves the way to novel therapeutic applications. Here we show that human cord blood (CB) CD133 + cells lose their hematopoietic signature and are converted into CB-induced neuronal-like cells (CB-iNCs) by the ectopic expression of the transcription factor Sox2, a process that is further augmented by the combination of Sox2 and c-Myc. Gene-expression analysis, immunophenotyping, and electrophysiological analysis show that CB-iNCs acquire a distinct neuronal phenotype characterized by the expression of multiple neuronal markers. CB-iNCs show the ability to fire action potentials after in vitro maturation as well as after in vivo transplantation into the mouse hippocampus. This system highlights the potential of CB cells and offers an alternative means to the study of cellular plasticity, possibly in the context of drug screening research and of future cell-replacement therapies.

1 April 2021 in Stem Cell Reports
Verified
Journal Article
Open access
KVKrishna C. Vadodaria
Krishna C. Vadodaria
AMAna P.D. Mendes
Ana P.D. Mendes
AMArianna Mei
Arianna Mei
VRVipula Racha
Vipula Racha
GEGalina Erikson
Galina Erikson
FGFred H. Gage
Fred H. Gage
Bipolar disorder (BD) is characterized by cyclical mood shifts. Studies indicate that BD patients have a peripheral pro-inflammatory state and alterations in glial populations in the brain. We utilized an in vitro model to study inflammation-related phenotypes of astrocytes derived from induced pluripotent stem cells (iPSCs) generated from BD patients and healthy controls. BD astrocytes showed changes in transcriptome and induced a reduction in neuronal activity when co-cultured with neurons. IL-1β-stimulated BD astrocytes displayed a unique inflammatory gene expression signature and increased secretion of IL-6. Conditioned medium from stimulated BD astrocytes reduced neuronal activity, and this effect was partially blocked by IL-6 inactivating antibody. Our results suggest that BD astrocytes are functionally less supportive of neuronal excitability and this effect is partially mediated by IL-6. We confirmed higher IL-6 in blood in a distinct cohort of BD patients, highlighting the potential role of astrocyte-mediated inflammatory signaling in BD neuropathology.

20 January 2022 in Stem Cell Reports
Verified
Journal Article
Open access
JWJack T. Whiteley
Jack T. Whiteley
SFSarah Fernandes
Sarah Fernandes
ASAmandeep Sharma
Amandeep Sharma
AMAna Paula D. Mendes
Ana Paula D. Mendes
VRVipula Racha
Vipula Racha
MMMaria C. Marchetto
Maria C. Marchetto
Recent advances in genetics, molecular biology, and stem cell biology have accelerated our understanding of neuropsychiatric disorders, like autism spectrum disorder (ASD), major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SZ). This progress highlights the incredible complexity of both the human brain and mental illnesses from the biochemical to the cellular level. Contributing to the complexity of neuropsychiatric disorders are their polygenic nature, cellular and brain region interconnectivity, and dysregulation of human-specific neurodevelopmental processes. Here, we discuss available tools, including CRISPR-Cas9, and the applications of these tools to develop cell-based two-dimensional (2D) models and 3D brain organoid models that better represent and unravel the intricacies of neuropsychiatric disorder pathophysiology.